Jekwon (Jay) Yeh, M.D., M.B.A.
Jekwon (Jay) Yeh, M.D., M.B.A., assistant clinical professor and radiation oncologist is the elected community representative of the Medical Executive Committee at City of Hope. He earned his medical degree from Boston University School of Medicine after graduating cum laude from University of California Irvine with a degree in molecular biology and biochemistry.
Dr. Yeh is a genitourinary cancer specialist and currently serves as a chairman on Elsevier’s ClinicalPath Genitourinary Cancer Team. He is responsible for reviewing the most recent published scientific data and establishing national treatment guidelines for prostate, bladder and testicular cancers. Dr. Yeh also serves on the genitourinary and head and neck cancer committees at City of Hope, where he evaluates promising leading-edge clinical trials.
Highly skilled in all forms of radiation therapy, Dr. Yeh specializes in the treatment of not only prostate, but also lung, gastrointestinal, brain, breast and other cancers. He has focused his research on minimizing the side effects of radiation therapy.
Dr. Yeh has extensive expertise in all forms of radiation therapy. As a high dose rate (HDR) brachytherapy specialist, Dr. Yeh has performed well over 1,000 HDR treatments for prostate, breast, cervical and endometrial cancer.
Dr. Yeh has an extensive background in research and has publications in major peer-reviewed journals, including the International Journal of Radiation Oncology, Biology, and Physics, American Journal of Clinical Oncology, and Brachytherapy. He has also presented numerous research studies at international scientific conferences.
Dr. Yeh is proud to be a part of City of Hope's family. “It is exciting to practice with a team that is always at the forefront of advancements in cancer treatment.”
2016, Augmenix SpaceOAR Rectal Spacer Implantation Certified
2014, American Board of Radiology, Board Certified in Radiation Oncology
California Medical Board/DEA
Advanced Cardiac Life Support/Basic Life Support
2019-2021, Master of Business Administration, Healthcare Management, Capella University, Minneapolis, MN
2004-2008, Doctor of Medicine, Boston University, MA
2000-2004, Bachelor of Science, Biochemistry and Molecular Biology, University of California Irvine, Irvine, CA
2009-2013, Resident Physician, PGY-5 Chief Resident, Kaiser Permanente Los Angeles Medical Center Department of Radiation Oncology, Los Angeles, CA
2008-2009, Department of Surgery, Flushing Hospital Medical Center, Queens, NY
2019-present, Assistant Clinical Professor, Department of Radiation Oncology, City of Hope, Glendale, CA
2017-2019, Medical Director, Rio Bravo Cancer Center, Bakersfield, CA
2013-2017, Radiation Oncology Attending Physician, Cancer Center of Irvine, Irvine, CA
2013-2017, Chairman, Continuing Medical Education CME Program at Cancer Center of Irvine, Irvine, CA
2016, Super Doctors Rising Star Recognition
2015, American Radium Society 2015 Meeting - Distinguished Poster
2013, Seattle Prostate Institute – Brachytherapy Training Grant Recipient
2012, Kaiser Permanente LAMC Insider Newsletter Featured for Outstanding Patient Care
2011, Kaiser Permanente Travel Award ASTRO 2011 Grant Recipient
2009, National Comprehensive Cancer Network Conference Grant Recipient
2005, BU Graduate Medical Sciences – Summer Research Program Grant Recipient
2003, UCI’s Undergraduate Research Opportunities Program Grant Recipient
2002, National Dean's List
2001, Induction into National Society of Collegiate Scholars
2000-2004, UCI Dean's List
2021-2022, Medical Executive Committee Member at City of Hope, Elected Community Representative
American Society for Radiation Oncology
American College of Radiation Oncology
American Society of Clinical Oncology
American Medical Association
Los Angeles Radiological Society
American Brachytherapy Society
National Society of Collegiate Scholars
- Tao A, Yeh J. Accelerated Partial-Breast Irradiation (APBI) Using High-Dose-Rate Interstitial Brachytherapy for Ductal Carcinoma In-Situ (DCIS). American Brachytherapy Society. 2017. (Boston, MA)
- Tao A, Yeh J. Accelerated Partial-Breast Irradiation (APBI) Using High-Dose-Rate Interstitial Brachytherapy for Invasive Ductal Carcinoma (IDC). American Brachytherapy Society. 2017. (Boston, MA)
- Yeh J. Combination HDR Brachytherapy and IMRT for the Treatment of Prostate Cancer. World Congress of Brachytherapy. 2016. (San Francisco, CA)
- Yeh J. Postprostatectomy Patients Undergoing Salvage High-Dose External Beam Radiation With a Polyethylene Glycol (PEG) Spacer. American Society for Radiation Oncology (ASTRO). 2016. (Boston, MA)
- Yeh J, Chien J. Absence of Infection From Injection of a Rectal Spacer Into the Anterior Perirectal Fat Space. American Radium Society. 2015. (Kauai, HI) - Poster of Distinction
- Yeh J, Chien J. Rectal Spacer Injection in Post-Prostatectomy Patients Undergoing Salvage High Dose External Beam Radiation. American Radium Society. 2015. (Kauai, HI)
- Tokita K, Yeh J. Spacer Enhanced HDR Provides New radiation Therapy Treatment Planning Options for HDR Brachytherapy. BrachyNext. 2014. (Miami Fl)
- Yeh J. Adenocarcinoma of the Anal Canal: A Single Institution Experience. ASTRO. 2013. (Atlanta, GA)
- Chang-Halpenny C, Yeh J. Elderly Patients with Glioblastoma Multiforme Treated with Concurrent Temozolomide and Standard versus Abbreviated Course Radiotherapy. ASTRO. 2013. (Atlanta, GA)
- Yeh J, Hastings J. Squamous Cell Carcinoma of the Rectum: A Single Institution Experience. ASTRO. 2011. (Miami, Fl)
- Yeh J. Evolving Treatment Paradigm of Anaplastic Carcinoma of the Thyroid. Kaiser Permanente Southern California Regional Radiation Oncology Educational Conference. April 2010. (Los Angeles, CA)
- Yeh J. Endometrial Carcinoma: High Dose Rate Brachytherapy Planning. Kaiser Permanente Southern California Regional Radiation Oncology Educational Conference. Aug. 2010. (Los Angeles, CA)
- Yeh J. Nasopharyngeal Carcinoma Treatment Management. Kaiser Permanente Southern California Regional Radiation Oncology Educational Conference. Feb 2011. (Los Angeles, CA)
- Yeh J. Limited Stage Small Cell Carcinoma of the Lung. Kaiser Permanente Southern California Regional Radiation Oncology Educational Conference. Oct. 11. (Los Angeles, CA)
- Yeh J. Post Mastectomy Radiation Therapy in Women With 1-3 Positive Axillary Lymph Nodes. Kaiser Permanente Southern California Regional Radiation Oncology Educational Conference. June 2021. (Los Angeles, CA)
- Yeh J, Lehrich B. Three-year outcomes of 324 prostate carcinoma patients treated with combination high-dose-rate brachytherapy and intensity modulated radiation therapy. Translational Cancer Research Journal. 2017.
- Yeh J, Lehrich B. Polyethylene Glycol Hydrogel Rectal Spacer Implantation in Patients With Prostate Cancer Undergoing Combination HDR Brachytherapy and External Beam Radiotherapy. Brachytherapy Journal. Feb. 2016.
- Chang-Halpenny C, Yeh J. Elderly Patients with Glioblastoma Multiforme Treated with Concurrent Temozolomide and Standard versus Abbreviated Course Radiotherapy. The Permanente Journal. Winter 2015.
- Kagan AR, Yeh J, Schulz RJ. Is Proton-Beam Therapy Better Than Intensity-Modulated Radiation Therapy for Prostate Cancer? American Journal Clinical Oncology. Feb. 26, 2014.
- Yeh J, Kagan AR. Ego-Based Medicine, International Journal of Radiation Oncology, Biology. Physics (IJROBP). May 2013.
- Yeh J, Hastings J. Squamous Cell Carcinoma of the Rectum: A Single Institution Experience. Journal of Coloproctology. Oct. 2012.